chr17:61554422:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr17:61,554,422-61,575,741 |
hg38 | chr17:63,477,061-63,498,380 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.008 | squamous cell carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Cardiomyopathy, Alcoholic | NA | BeFree | Detail | |
0.007 | Cardiomyopathy, Dilated | NA | BeFree,GAD,LHGDN | Detail | |
0.024 | hypertrophic cardiomyopathy | NA | BeFree,GAD,LHGDN | Detail | |
0.261 | Cardiovascular Diseases | New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogen... | BeFree,CTD_human,GAD,LHGDN | 24690767 | Detail |
0.012 | Carotid Artery Diseases | NA | BeFree,GAD | Detail | |
0.003 | carotid stenosis | NA | BeFree,GAD | Detail | |
0.002 | cellulitis | NA | GAD | Detail | |
0.006 | intracranial aneurysm | NA | BeFree,GAD | Detail | |
0.005 | intracranial arteriosclerosis | NA | GAD | Detail | |
0.003 | cerebral atherosclerosis | NA | BeFree,GAD | Detail | |
0.019 | cerebral infarction | NA | BeFree,GAD | Detail | |
0.165 | brain ischemia | NA | CTD_human,GAD | Detail | |
0.003 | Transient ischemic attack | NA | BeFree,GAD | Detail | |
0.012 | Cerebrovascular Disorders | NA | GAD | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
<0.001 | Chagas Cardiomyopathy | NA | BeFree | Detail | |
<0.001 | Chest Pain | NA | BeFree | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
0.002 | Chromosome Aberrations | NA | GAD | Detail | |
<0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.007 | Chromosome Deletion | NA | GAD | Detail | |
0.012 | Cicatrization | NA | GAD | Detail | |
0.002 | Cognition Disorders | NA | GAD | Detail | |
0.003 | ulcerative colitis | NA | BeFree,GAD | Detail | |
0.001 | colorectal carcinoma | Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal... | BeFree | 25889770 | Detail |
0.005 | Colorectal Neoplasms | NA | GAD,LHGDN | Detail | |
0.007 | Connective Tissue Diseases | NA | GAD,LHGDN | Detail | |
0.002 | Convalescence | NA | GAD | Detail | |
<0.001 | coronary aneurysm | NA | BeFree | Detail | |
0.003 | coronary thrombosis | NA | BeFree,GAD | Detail | |
<0.001 | coronary artery vasospasm | NA | BeFree | Detail | |
<0.001 | Chronic cough | NA | BeFree | Detail | |
0.006 | Crohn Disease | NA | BeFree,GAD | Detail | |
0.003 | Cushing syndrome | NA | BeFree,GAD | Detail | |
0.005 | cystic fibrosis | NA | BeFree,GAD | Detail | |
0.120 | Sudden death | NA | CTD_human | Detail | |
0.005 | Presenile dementia | In 118 subjects from the memory clinic based Amsterdam Dementia Cohort (mean age... | BeFree | 25201786 | Detail |
0.011 | Dementia, Vascular | NA | BeFree,GAD,LHGDN | Detail | |
0.013 | Mental Depression | NA | BeFree,GAD | Detail | |
0.006 | depressive disorder | Previous studies have revealed the association of the ACE gene insertion/deletio... | BeFree,GAD | 25694211 | Detail |
0.002 | contact dermatitis | NA | GAD | Detail | |
0.200 | Diabetes Mellitus, Experimental | NA | CTD_human,RGD | Detail | |
0.066 | Diabetes Mellitus, Insulin-Dependent | Non-dipping and arterial hypertension depend on clinical factors rather than on ... | BeFree,GAD | 24562335 | Detail |
0.010 | Diabetic Angiopathies | NA | BeFree,GAD | Detail | |
0.332 | Diabetic Nephropathy | The distribution of ACE (I/D) II 28.8%, ID 35.6% and DD 35.6% while in DN II 24.... | BeFree,CTD_human,GAD,LHGDN,RGD | 24737640 | Detail |
0.332 | Diabetic Nephropathy | ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implicati... | BeFree,CTD_human,GAD,LHGDN,RGD | 25587546 | Detail |
0.332 | Diabetic Nephropathy | Genetic variants in angiotensin-converting enzyme (ACE), tumor necrosis factor-a... | BeFree,CTD_human,GAD,LHGDN,RGD | 25656761 | Detail |
0.332 | Diabetic Nephropathy | Influence of genetic variability at the ACE locus in intron 16 on Diabetic Nephr... | BeFree,CTD_human,GAD,LHGDN,RGD | 26214998 | Detail |
0.007 | Diabetic Neuropathies | NA | GAD | Detail | |
0.025 | diabetic retinopathy | NA | BeFree,GAD | Detail | |
0.007 | Pathological Dilatation | NA | GAD | Detail | |
0.005 | DNA Damage | NA | GAD | Detail | |
0.123 | drug allergy | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Muscular Dystrophy, Duchenne | NA | BeFree | Detail | |
<0.001 | duodenal ulcer | NA | BeFree | Detail | |
0.002 | eclampsia | The mechanisms may include the following pathways: [TGFB1 or TNFA]-[IL1B]-[pre-e... | BeFree | 25879409 | Detail |
0.002 | Edema | NA | GAD | Detail | |
0.002 | Pathological accumulation of air in tissues | NA | GAD | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
0.002 | Endometrial Neoplasms | NA | GAD | Detail | |
0.014 | endometriosis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Epilepsy, Temporal Lobe | NA | BeFree | Detail | |
0.002 | Escherichia coli Infections | NA | GAD | Detail | |
0.005 | Esophageal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Esophageal Varices | NA | BeFree,GAD | Detail | |
0.002 | Disorder of eye | NA | GAD | Detail | |
0.005 | Fatigue | NA | BeFree,GAD,LHGDN | Detail | |
0.007 | chronic fatigue syndrome | NA | GAD,LHGDN | Detail | |
0.002 | Femur Head Necrosis | NA | GAD | Detail | |
0.002 | Fetal Death | NA | GAD | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.007 | Fetal Growth Retardation | NA | GAD | Detail | |
0.005 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
0.003 | Fibromuscular Dysplasia | NA | BeFree,GAD | Detail | |
<0.001 | fibromyalgia | Angiotensin converting enzyme and methylenetetrahydrofolate reductase gene varia... | BeFree | 25824380 | Detail |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
0.010 | Fibrosis | NA | GAD,LHGDN | Detail | |
<0.001 | pathologic fistula | NA | BeFree | Detail | |
<0.001 | Gangrene | NA | BeFree | Detail | |
<0.001 | gastritis | NA | BeFree | Detail | |
0.003 | Gastritis, Atrophic | NA | BeFree,GAD | Detail | |
<0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
0.002 | Gastrointestinal Diseases | NA | GAD | Detail | |
0.002 | Gastrointestinal Hemorrhage | NA | GAD | Detail | |
0.002 | Gastrointestinal Neoplasms | NA | GAD | Detail | |
0.122 | Gaucher disease | NA | CTD_human,GAD | Detail | |
<0.001 | Gingival Diseases | ACE insertion/deletion polymorphism is associated with periodontal disease in Ko... | BeFree | 25555251 | Detail |
0.002 | glaucoma | NA | GAD | Detail | |
0.010 | Glaucoma, Open-Angle | NA | GAD,LHGDN | Detail | |
<0.001 | glioblastoma | NA | BeFree | Detail | |
0.083 | glomerulonephritis | NA | BeFree,GAD,RGD | Detail | |
0.177 | IgA glomerulonephritis | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | membranous glomerulonephritis | NA | BeFree | Detail | |
<0.001 | Nodular glomerulosclerosis | NA | BeFree | Detail | |
0.024 | Focal glomerulosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Glycogen storage disease type II | NA | BeFree,GAD | Detail | |
0.133 | Glycogen Storage Disease Type V | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.005 | Graft Occlusion, Vascular | NA | GAD | Detail | |
0.002 | Graft-vs-Host Disease | NA | GAD | Detail | |
<0.001 | Headache | NA | BeFree | Detail | |
<0.001 | cardiac arrest | NA | BeFree | Detail | |
<0.001 | Heart block | NA | BeFree | Detail | |
0.003 | congenital heart defects | Based on some research evidence, treatment with angiotensin-converting enzyme in... | BeFree,GAD | 24488829 | Detail |
0.014 | Heart Diseases | NA | BeFree,GAD | Detail | |
0.008 | Cardiomegaly | NA | GAD,LHGDN | Detail | |
0.277 | Heart failure | The HF pharmacogenetic literature is still in its very early stages, but there a... | BeFree,CTD_human,GAD,LHGDN,RGD | 25150872 | Detail |
0.024 | congestive heart failure | The HF pharmacogenetic literature is still in its very early stages, but there a... | BeFree | 25150872 | Detail |
0.007 | heart valve disease | NA | BeFree,GAD | Detail | |
0.002 | hemolytic-uremic syndrome | NA | GAD | Detail | |
<0.001 | hepatitis B | To design a tumor-specific retroviral replicating vector (RRV), we replaced the ... | BeFree | 25354682 | Detail |
<0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
0.008 | hepatitis C | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | hepatorenal syndrome | NA | GAD | Detail | |
<0.001 | Angioedemas, Hereditary | The FXII-HAE is associated with modifiers, for example kinin catabolism enzymes,... | BeFree | 25134986 | Detail |
0.003 | Diaphragmatic hernia | NA | LHGDN | Detail | |
0.003 | HIV Infections | HIV status was associated with significantly increased expression of CD64, CD143... | BeFree,GAD | 25544986 | Detail |
0.001 | Hodgkin Disease | NA | BeFree | Detail | |
0.001 | Huntington disease | NA | BeFree | Detail | |
0.002 | hydrocephalus | NA | GAD | Detail | |
<0.001 | Hydrocephalus, Normal Pressure | NA | BeFree | Detail | |
0.002 | hydronephrosis | NA | GAD | Detail | |
0.010 | Hypercholesterolemia | NA | BeFree,GAD | Detail | |
0.003 | Hypercholesterolemia, Familial | NA | BeFree,GAD | Detail | |
0.004 | hyperglycemia | NA | BeFree,GAD | Detail | |
<0.001 | hyperinsulinism | ACE genotype and salt status do not impact on insulin sensitivity through change... | BeFree | 25154650 | Detail |
0.010 | Hyperlipidemia | NA | BeFree,GAD | Detail | |
<0.001 | Hyperlipoproteinemias | The angiotensin-converting enzyme gene polymorphism is associated with the devel... | BeFree | 25546976 | Detail |
0.002 | Hyperparathyroidism, Secondary | NA | GAD | Detail | |
0.002 | Hyperplasia | NA | GAD | Detail | |
0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
<0.001 | malignant hypertension | NA | BeFree | Detail | |
0.003 | Hypertension, Portal | NA | BeFree,GAD | Detail | |
0.136 | pulmonary hypertension | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.010 | renal hypertension | NA | BeFree,GAD | Detail | |
0.081 | Hypertension, Renovascular | NA | BeFree,RGD | Detail | |
<0.001 | Hypertensive crisis | NA | BeFree | Detail | |
<0.001 | hyperthyroidism | NA | BeFree | Detail | |
0.003 | Hypertriglyceridemia | NA | LHGDN | Detail | |
0.017 | hypoglycemia | NA | BeFree,GAD,LHGDN | Detail | |
0.120 | Hypotension | NA | CTD_human | Detail | |
0.005 | Hypotension, Orthostatic | NA | GAD,LHGDN | Detail | |
0.125 | Infant, Premature, Diseases | NA | CTD_human,GAD | Detail | |
0.121 | male infertility | NA | BeFree,CTD_human | Detail | |
0.007 | Inflammation | NA | GAD | Detail | |
0.013 | Inflammatory Bowel Diseases | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | influenza | In comparison tests with Seeplex RV15 ACE Detection RT-PCR, the sensitivity of t... | BeFree | 24797766 | Detail |
0.031 | Insulin resistance | NA | GAD | Detail | |
0.002 | intermittent claudication | NA | GAD | Detail | |
0.003 | ischemia | NA | BeFree,GAD | Detail | |
0.002 | arthropathy | NA | GAD | Detail | |
0.008 | Kidney Failure, Acute | NA | BeFree,GAD | Detail | |
0.224 | Kidney Failure, Chronic | Impact of interaction of cigarette smoking with angiotensin-converting enzyme po... | BeFree,CTD_human,GAD,LHGDN | 23477970 | Detail |
0.224 | Kidney Failure, Chronic | Although angiotensin-converting enzyme inhibition is effective in Alport syndrom... | BeFree,CTD_human,GAD,LHGDN | 24988067 | Detail |
0.012 | Polycystic Kidney Diseases | NA | BeFree,GAD | Detail | |
0.005 | Premature Obstetric Labor | NA | GAD | Detail | |
0.006 | Fibroid Tumor | We conclude that the ACE gene I/D polymorphism is not related with the size or n... | BeFree,GAD,LHGDN | 25735342 | Detail |
0.005 | leukemia | NA | GAD,LHGDN | Detail | |
0.003 | Leukemia, Myelocytic, Acute | NA | BeFree,LHGDN | Detail | |
0.013 | Mental Depression | To investigate the possible relationship between genetic risk factors and depres... | BeFree | 23157339 | Detail |
0.006 | depressive disorder | To investigate the possible relationship between genetic risk factors and depres... | BeFree | 23157339 | Detail |
0.003 | major depressive disorder | To investigate the possible relationship between genetic risk factors and depres... | BeFree | 23157339 | Detail |
0.004 | Unipolar Depression | To investigate the possible relationship between genetic risk factors and depres... | BeFree | 23157339 | Detail |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
0.002 | Hyperlipoproteinemia Type I | NA | GAD | Detail | |
0.088 | liver cirrhosis | NA | BeFree,GAD,RGD | Detail | |
0.080 | Biliary cirrhosis | NA | RGD | Detail | |
0.005 | Liver diseases | NA | BeFree,GAD | Detail | |
0.007 | long QT syndrome | NA | GAD | Detail | |
0.002 | Low Back Pain | NA | GAD | Detail | |
0.208 | Lung diseases | NA | BeFree,CTD_human,GAD,RGD | Detail | |
0.044 | Chronic Obstructive Airway Disease | Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor fo... | BeFree,GAD,LHGDN | 25511026 | Detail |
0.127 | Lung Neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
0.011 | Lupus Vulgaris | NA | BeFree,GAD | Detail | |
0.011 | Lupus Erythematosus, Discoid | NA | BeFree,GAD | Detail | |
0.052 | Lupus Erythematosus, Systemic | NA | BeFree,GAD,LHGDN | Detail | |
0.013 | lupus nephritis | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Lymphatic Metastasis | NA | GAD | Detail | |
0.003 | lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | Lymphoma, Non-Hodgkin | NA | BeFree | Detail | |
<0.001 | malaria | NA | BeFree | Detail | |
0.003 | Malaria, Cerebral | NA | BeFree,GAD | Detail | |
0.005 | Malignant neoplasm of stomach | Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer... | BeFree,GAD | 25154002 | Detail |
0.002 | Marfan syndrome | NA | GAD | Detail | |
0.002 | meconium aspiration syndrome | NA | GAD | Detail | |
<0.001 | melanoma | NA | BeFree | Detail | |
0.080 | Memory Disorders | NA | RGD | Detail | |
0.123 | Meningococcal Infections | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Microangiopathy, Diabetic | NA | BeFree | Detail | |
0.002 | mitral valve insufficiency | NA | GAD | Detail | |
0.006 | Mitral Valve Prolapse Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | mitral valve stenosis | NA | BeFree | Detail | |
0.007 | Mouth Neoplasms | NA | GAD | Detail | |
0.014 | Mucocutaneous Lymph Node Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | multiple sclerosis | NA | BeFree,GAD | Detail | |
<0.001 | Muscle Rigidity | NA | BeFree | Detail | |
0.003 | Musculoskeletal Diseases | NA | BeFree,GAD | Detail | |
0.002 | myasthenia gravis | NA | GAD | Detail | |
0.005 | Myotonic dystrophy | NA | GAD | Detail | |
0.121 | Neoplasm Metastasis | NA | BeFree,CTD_human | Detail | |
0.007 | nephritis | NA | BeFree,GAD | Detail | |
<0.001 | Hereditary nephritis | NA | BeFree | Detail | |
0.002 | Nephritis, Interstitial | NA | GAD | Detail | |
<0.001 | nephrosclerosis | NA | BeFree | Detail | |
0.080 | nephrosis | NA | RGD | Detail | |
0.005 | lipoid nephrosis | NA | GAD | Detail | |
0.034 | nephrotic syndrome | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
0.002 | neutropenia | NA | GAD | Detail | |
<0.001 | Obesity, Morbid | NA | BeFree | Detail | |
0.002 | ocular hypertension | NA | GAD | Detail | |
0.002 | Disorder of the optic nerve | NA | GAD | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
0.002 | Bone necrosis | NA | GAD | Detail | |
0.080 | osteoporosis | Association between the ACE gene I/D polymorphism and osteoporosis in a Turkish ... | BeFree,RGD | 25876051 | Detail |
0.002 | otosclerosis | NA | GAD | Detail | |
0.246 | Coronary heart disease | Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic eff... | BeFree | 24827774 | Detail |
0.001 | Ovarian Diseases | NA | BeFree | Detail | |
<0.001 | Overanxious disorder | NA | BeFree | Detail | |
0.080 | Pain | NA | RGD | Detail | |
0.002 | Pain, Postoperative | NA | GAD | Detail | |
0.002 | Pancreatic Diseases | NA | GAD | Detail | |
0.072 | Coronary Arteriosclerosis | Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic eff... | BeFree | 24827774 | Detail |
0.002 | Pancreatic Pseudocyst | NA | GAD | Detail | |
0.003 | pancreatitis | NA | BeFree,GAD | Detail | |
0.001 | panic disorder | The relationship between ACE polymorphism and panic disorder. | BeFree | 25189904 | Detail |
0.010 | Parkinson disease | NA | GAD,LHGDN | Detail | |
0.003 | Peptic Ulcer | NA | BeFree,GAD | Detail | |
0.002 | Peptic Ulcer Hemorrhage | NA | GAD | Detail | |
0.003 | Chronic glomerulonephritis | We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting en... | BeFree | 23681285 | Detail |
<0.001 | familial Mediterranean fever | NA | BeFree | Detail | |
<0.001 | Periodontal Diseases | ACE insertion/deletion polymorphism is associated with periodontal disease in Ko... | BeFree | 25555251 | Detail |
0.005 | periodontitis | NA | GAD | Detail | |
0.003 | Peripheral neuropathy | NA | BeFree,LHGDN | Detail | |
<0.001 | Pleural effusion disorder | NA | BeFree | Detail | |
0.122 | Pneumonia, Viral | NA | CTD_human,GAD | Detail | |
0.011 | polycystic ovary syndrome | NA | BeFree,GAD | Detail | |
0.009 | polycythemia | NA | BeFree,GAD | Detail | |
0.002 | Adenomatous Polyposis Coli | NA | GAD | Detail | |
0.014 | Postoperative Complications | NA | GAD | Detail | |
0.166 | pre-eclampsia | NA | CTD_human,GAD,LHGDN | Detail | |
0.002 | Precancerous Conditions | NA | GAD | Detail | |
0.007 | Pregnancy Complications | NA | BeFree,GAD | Detail | |
0.005 | Pregnancy Complications, Cardiovascular | NA | GAD | Detail | |
0.007 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
0.125 | Prostatic Neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
0.024 | proteinuria | NA | GAD | Detail | |
0.018 | psoriasis | The angiotensin-converting enzyme insertion/deletion polymorphism and susceptibi... | BeFree,GAD,LHGDN | 23413281 | Detail |
0.018 | psoriasis | Evaluation of the association between CD143 gene polymorphism and psoriasis. | BeFree,GAD,LHGDN | 24997622 | Detail |
0.120 | Psychoses, Substance-Induced | NA | CTD_human | Detail | |
<0.001 | pterygium | Association between the ACE insertion/deletion polymorphism and pterygium in Sar... | BeFree | 25341451 | Detail |
0.002 | Puerperal Disorders | NA | GAD | Detail | |
0.015 | pulmonary edema | NA | GAD,LHGDN | Detail | |
0.008 | pulmonary embolism | NA | BeFree,GAD | Detail | |
0.083 | pulmonary fibrosis | NA | BeFree,GAD,RGD | Detail | |
0.006 | Henoch-Schoenlein purpura | NA | BeFree,GAD | Detail | |
0.002 | pyelonephritis | NA | GAD | Detail | |
0.003 | Raynaud disease | NA | BeFree,GAD | Detail | |
0.002 | reflex sympathetic dystrophy | NA | GAD | Detail | |
0.002 | renal artery obstruction | NA | GAD | Detail | |
0.003 | Renal Artery Stenosis | NA | BeFree,GAD | Detail | |
0.025 | kidney failure | NA | BeFree,GAD | Detail | |
0.082 | Reperfusion Injury | NA | GAD,RGD | Detail | |
0.001 | Respiration Disorders | NA | BeFree | Detail | |
0.006 | Respiratory Distress Syndrome, Newborn | NA | BeFree,GAD | Detail | |
0.022 | Respiratory Distress Syndrome, Adult | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Respiratory Insufficiency | NA | GAD | Detail | |
<0.001 | Respiratory Syncytial Virus Infections | These results suggest that DCP1 phosphorylation modulates the host chemokine res... | BeFree | 25796077 | Detail |
0.122 | Respiratory Tract Diseases | NA | CTD_human,GAD | Detail | |
0.003 | retinal artery occlusion | NA | BeFree,GAD | Detail | |
<0.001 | retinal detachment | NA | BeFree | Detail | |
0.011 | Retinal Diseases | NA | BeFree,GAD | Detail | |
0.002 | retinal vascular occlusion | NA | GAD | Detail | |
<0.001 | retinal vein occlusion | NA | BeFree | Detail | |
0.006 | retinopathy of prematurity | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Rhabdomyolysis | NA | GAD | Detail | |
0.003 | rheumatic fever | NA | BeFree,GAD | Detail | |
0.011 | rheumatic heart disease | Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi pati... | BeFree,GAD | 25719581 | Detail |
0.002 | Rhinitis, Allergic, Perennial | NA | GAD | Detail | |
0.043 | sarcoidosis | Associations between the angiotensin-converting enzyme insertion/deletion polymo... | BeFree,GAD,LHGDN | 23676252 | Detail |
0.043 | sarcoidosis | In this study, we developed a new method for genotyping the I/D polymorphism in ... | BeFree,GAD,LHGDN | 24696153 | Detail |
0.008 | Sarcoidosis, Pulmonary | NA | BeFree,GAD | Detail | |
0.022 | schizophrenia | Association of angiotensin-converting enzyme gene polymorphism with schizophreni... | BeFree,GAD,LHGDN | 25694211 | Detail |
0.017 | systemic scleroderma | Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility... | BeFree,GAD,LHGDN | 25299202 | Detail |
0.004 | Seizures | We investigated misspecification, and found that fitting the standard ACE simple... | BeFree,GAD | 24789102 | Detail |
<0.001 | seminoma | NA | BeFree | Detail | |
0.001 | Septicemia | Increased susceptibility of sepsis associated with CD143 deletion/insertion poly... | BeFree | 25400733 | Detail |
0.005 | Shock | NA | GAD | Detail | |
0.002 | Septic Shock | NA | GAD | Detail | |
0.005 | Dermatologic disorders | The genetic contribution of CD143 ID polymorphism to the progression of psoriasi... | BeFree,GAD | 24997622 | Detail |
0.002 | Skin Diseases, Genetic | NA | GAD | Detail | |
0.006 | Sleep Apnea Syndromes | NA | BeFree,GAD | Detail | |
0.002 | Sleep Deprivation | NA | GAD | Detail | |
0.002 | Snoring | NA | GAD | Detail | |
0.006 | ankylosing spondylitis | NA | BeFree,GAD,LHGDN | Detail | |
0.120 | Staphylococcal Infections | NA | CTD_human | Detail | |
0.135 | Stomach Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | gastric ulcer | NA | BeFree | Detail | |
0.002 | Streptococcal Infections | NA | GAD | Detail | |
<0.001 | post-traumatic stress disorder | Common antihypertensive medication classes of angiotensin-converting enzyme inhi... | BeFree | 25921615 | Detail |
<0.001 | Stress, Psychological | NA | BeFree | Detail | |
0.300 | Cerebrovascular accident | In pharmacogenetic analysis, the increased risk of stroke in subjects carrying G... | BeFree,CTD_human,GAD,LHGDN,RGD | 24732371 | Detail |
0.300 | Cerebrovascular accident | The angiotensin-converting enzyme gene polymorphism is associated with the devel... | BeFree,CTD_human,GAD,LHGDN,RGD | 25546976 | Detail |
0.003 | subacute sclerosing panencephalitis | NA | BeFree,LHGDN | Detail | |
0.008 | Subarachnoid Hemorrhage | In this paper we show that upon an appropriate design of the biorecognition plat... | BeFree,GAD | 25653060 | Detail |
0.003 | Substance Withdrawal Syndrome | NA | BeFree,GAD | Detail | |
0.003 | Syncope | NA | BeFree,GAD | Detail | |
0.003 | Tachycardia | NA | BeFree,LHGDN | Detail | |
<0.001 | Tachycardia, Ectopic Junctional | NA | BeFree | Detail | |
<0.001 | Takayasu Arteritis | NA | BeFree | Detail | |
0.009 | Thromboembolism | NA | BeFree,GAD | Detail | |
0.014 | thrombosis | NA | GAD | Detail | |
0.007 | Tobacco use disorder | NA | GAD | Detail | |
0.002 | Chromosomal translocation | NA | GAD | Detail | |
<0.001 | Tremor | NA | BeFree | Detail | |
0.002 | tricuspid valve insufficiency | NA | GAD | Detail | |
<0.001 | Chagas disease | NA | BeFree | Detail | |
0.003 | tuberculosis | NA | BeFree,LHGDN | Detail | |
0.003 | Tuberculosis, Pulmonary | NA | BeFree,GAD | Detail | |
<0.001 | Turner syndrome | NA | BeFree | Detail | |
0.004 | Unipolar Depression | NA | BeFree | Detail | |
0.003 | uremia | NA | BeFree,GAD | Detail | |
0.002 | Urinary Incontinence | NA | GAD | Detail | |
0.010 | urinary tract infection | NA | BeFree,GAD | Detail | |
<0.001 | Urologic Diseases | NA | BeFree | Detail | |
0.006 | urticaria | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Uterine Fibroids | Lack of influence of the ACE1 gene I/D polymorphism on the formation and growth ... | BeFree | 25735342 | Detail |
0.020 | Vascular Diseases | NA | BeFree,GAD | Detail | |
0.007 | Vasovagal syncope | NA | BeFree,GAD | Detail | |
0.019 | Venous Thrombosis | NA | GAD,LHGDN | Detail | |
0.002 | Ventricular fibrillation | NA | GAD | Detail | |
0.002 | Tachycardia, Ventricular | NA | GAD | Detail | |
0.030 | Vesico-Ureteral Reflux | NA | BeFree,GAD | Detail | |
<0.001 | Virus Diseases | NA | BeFree | Detail | |
0.009 | vitiligo | NA | BeFree,GAD | Detail | |
0.003 | Water Intoxication | NA | BeFree,LHGDN | Detail | |
0.012 | Weight Gain | NA | GAD | Detail | |
<0.001 | Werner syndrome | NA | BeFree | Detail | |
0.002 | Accelerated Idioventricular Rhythm | NA | GAD | Detail | |
0.019 | Peripheral Vascular Diseases | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
0.003 | Bronchial Hyperreactivity | NA | BeFree,GAD | Detail | |
<0.001 | seasonal affective disorder | NA | BeFree | Detail | |
0.003 | gestational diabetes | Angiotensin-converting enzyme gene insertion/deletion polymorphism studies in As... | BeFree,GAD | 24189507 | Detail |
<0.001 | Ovarian Failure, Premature | NA | BeFree | Detail | |
0.009 | Sudden cardiac death | NA | GAD | Detail | |
0.014 | Polycystic Kidney, Autosomal Dominant | NA | BeFree,GAD,LHGDN | Detail | |
0.080 | autosomal recessive polycystic kidney disease | NA | RGD | Detail | |
0.033 | essential hypertension | ACE I/D, AGT M235T, and ADD Gly460Trp polymorphisms are thought to be associated... | BeFree,GAD | 25262176 | Detail |
<0.001 | Encephalopathies | NA | BeFree | Detail | |
0.003 | Polydipsia | NA | BeFree,GAD | Detail | |
<0.001 | acute leukemia | The aim of this study was to investigate the mannose-binding lectin 2 (MBL-2), i... | BeFree | 24819208 | Detail |
<0.001 | Depressive Symptoms | Association of angiotensin-converting enzyme gene polymorphism with schizophreni... | BeFree | 25694211 | Detail |
<0.001 | cataract | NA | BeFree | Detail | |
0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
0.318 | Left Ventricular Hypertrophy | Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressu... | BeFree,CTD_human,GAD,LHGDN,RGD | 26336879 | Detail |
0.001 | Deep Vein Thrombosis | NA | BeFree | Detail | |
0.026 | Migraine Disorders | In patients with contraindications or not responding to conventional prophylacti... | BeFree,GAD,LHGDN | 25115162 | Detail |
0.002 | Congenital musculoskeletal anomalies | NA | GAD | Detail | |
0.014 | Premature Birth | NA | GAD | Detail | |
0.002 | Intracranial Hemorrhages | NA | GAD | Detail | |
0.036 | Myocardial Ischemia | NA | BeFree,GAD | Detail | |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | hypertensive heart disease | NA | BeFree | Detail | |
<0.001 | Drug withdrawal syndrome | NA | BeFree | Detail | |
0.003 | Chronic glomerulonephritis | We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting en... | BeFree,GAD | 23681285 | Detail |
<0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
<0.001 | Recurrent major depressive episodes | NA | BeFree | Detail | |
0.011 | migraine with aura | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | proliferative diabetic retinopathy | NA | BeFree,GAD | Detail | |
0.002 | Optic Neuropathy, Ischemic | NA | GAD | Detail | |
<0.001 | secondary hypertension | We suggest that RAS gene polymorphisms (ACE-I/D, AGT M235T) are significantly as... | BeFree | 25262176 | Detail |
0.007 | acute myocardial infarction | NA | BeFree | Detail | |
0.003 | Old myocardial infarction | NA | BeFree | Detail | |
<0.001 | Atherosclerosis of aorta | NA | BeFree | Detail | |
<0.001 | Disease of capillaries | NA | BeFree | Detail | |
0.081 | Right Ventricular Hypertrophy | NA | BeFree,RGD | Detail | |
0.003 | Dermatitis, Allergic Contact | NA | BeFree,LHGDN | Detail | |
0.005 | Aneurysm, Ruptured | NA | BeFree,GAD | Detail | |
0.024 | Aortic Aneurysm, Abdominal | A meta-analysis was conducted on the associations between the ACE I/D polymorphi... | BeFree,GAD,LHGDN | 23587545 | Detail |
<0.001 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | urinary tract obstruction | NA | BeFree | Detail | |
<0.001 | Germ cell tumor | NA | BeFree | Detail | |
<0.001 | Pneumonia, Interstitial | NA | BeFree | Detail | |
0.002 | Lung Diseases, Interstitial | NA | GAD | Detail | |
0.005 | Microvascular Angina | NA | BeFree,GAD | Detail | |
0.003 | hyperandrogenism | NA | BeFree,GAD | Detail | |
0.002 | Diabetic Foot | NA | GAD | Detail | |
0.002 | exfoliation syndrome | NA | GAD | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
0.001 | diastrophic dysplasia | NA | BeFree | Detail | |
<0.001 | Chronic berylliosis | NA | BeFree | Detail | |
<0.001 | Systolic hypertension | NA | BeFree | Detail | |
<0.001 | Welts | NA | BeFree | Detail | |
<0.001 | Chronic schizophrenia | NA | BeFree | Detail | |
0.003 | Fibrillation | NA | BeFree | Detail | |
0.003 | Memory impairment | NA | BeFree,GAD | Detail | |
<0.001 | Extrapyramidal sign | NA | BeFree | Detail | |
0.002 | Mental deterioration | NA | GAD | Detail | |
<0.001 | Diastolic hypertension | NA | BeFree | Detail | |
<0.001 | congenital diaphragmatic hernia | BH-DIH prevalence was significantly higher in subjects showing ACE ID genotype (... | BeFree | 26094307 | Detail |
<0.001 | Cerebral atrophy | Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy. | BeFree | 25201786 | Detail |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
0.002 | Substance-Related Disorders | NA | GAD | Detail | |
<0.001 | Acute mountain sickness | NA | BeFree | Detail | |
0.003 | Congenital posterior urethral valves | NA | BeFree,GAD | Detail | |
<0.001 | Left atrial hypertrophy | NA | BeFree | Detail | |
0.002 | Fibrosis, Liver | In addition, both AT1 blocker administration and ACE inhibitors lead to a reduct... | BeFree | 25453980 | Detail |
<0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
0.002 | Hypoxia | NA | GAD | Detail | |
0.022 | coronary stenosis | NA | BeFree,GAD,LHGDN | Detail | |
0.007 | Dyslipidemias | NA | BeFree,GAD | Detail | |
0.020 | Erectile dysfunction | NA | BeFree,GAD,LHGDN | Detail | |
0.007 | Malignant neoplasm of lung | Angiotensin-converting enzyme insertion/deletion gene polymorphism and lung canc... | BeFree,GAD | 25354524 | Detail |
0.007 | Malignant neoplasm of lung | Interaction of tobacco smoking and chewing with Angiotensin converting enzyme (i... | BeFree,GAD | 25605160 | Detail |
0.011 | age related macular degeneration | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Drug usage | The sample consisted of 205 subjects assessed for five types of episodic memory,... | BeFree | 24696269 | Detail |
0.003 | Disease Progression | NA | LHGDN | Detail | |
0.014 | Ventricular Dysfunction, Left | NA | GAD | Detail | |
0.002 | Ventricular Dysfunction, Right | NA | GAD | Detail | |
0.011 | Sepsis | Increased susceptibility of sepsis associated with CD143 deletion/insertion poly... | BeFree,GAD | 25400733 | Detail |
<0.001 | Borderline hypertension | NA | BeFree | Detail | |
<0.001 | chronic urticaria | NA | BeFree | Detail | |
<0.001 | Coronary artery atheroma | NA | BeFree | Detail | |
0.005 | Chronic heart failure | NA | BeFree,GAD | Detail | |
<0.001 | Ventricular dilatation (disorder) | NA | BeFree | Detail | |
<0.001 | Unilateral agenesis of kidney | NA | BeFree | Detail | |
0.003 | Chronic Periodontitis | NA | BeFree,GAD | Detail | |
<0.001 | Fibrosis of pancreas | NA | BeFree | Detail | |
0.003 | Cholestasis of pregnancy | NA | BeFree,GAD | Detail | |
<0.001 | 5,10-Methylenetetrahydrofolate reductase deficiency | NA | BeFree | Detail | |
0.002 | Renal glomerular disease | NA | BeFree | Detail | |
<0.001 | Renal vascular disorder | NA | BeFree | Detail | |
0.004 | Impaired glucose tolerance | NA | BeFree,LHGDN | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
0.002 | Heat Stress Disorders | NA | GAD | Detail | |
0.002 | persian gulf syndrome | NA | GAD | Detail | |
<0.001 | Very Low Birth Weight | NA | BeFree | Detail | |
<0.001 | Infant, Very Low Birth Weight | NA | BeFree | Detail | |
<0.001 | cervix carcinoma | NA | BeFree | Detail | |
0.006 | Obesity, Abdominal | NA | BeFree,GAD | Detail | |
0.018 | Restenosis | NA | BeFree,GAD | Detail | |
<0.001 | Senile Plaques | NA | BeFree | Detail | |
<0.001 | Segmental glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | Infarction, Lacunar | NA | BeFree | Detail | |
0.265 | coronary artery disease | Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (p... | BeFree | 21157371 | Detail |
0.001 | Common Migraine | NA | BeFree | Detail | |
0.008 | Impaired cognition | NA | BeFree,GAD | Detail | |
0.003 | Age-associated memory impairment | NA | BeFree,GAD | Detail | |
0.001 | Proliferative retinopathy | NA | BeFree | Detail | |
<0.001 | Glaucoma, Primary Open Angle | NA | BeFree | Detail | |
0.002 | High altitude pulmonary edema | Positive Association of D Allele of ACE Gene With High Altitude Pulmonary Edema ... | BeFree | 25683681 | Detail |
<0.001 | Ventricular hypertrophy | NA | BeFree | Detail | |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Silent myocardial ischemia | NA | BeFree | Detail | |
<0.001 | Anterior myocardial infarction | NA | BeFree | Detail | |
<0.001 | Lone atrial fibrillation | NA | BeFree | Detail | |
<0.001 | High altitude pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Aortic aneurysm without mention of rupture NOS | Associations between the insertion/deletion polymorphism of the angiotensin-conv... | BeFree | 23587545 | Detail |
<0.001 | Aortic aneurysm without mention of rupture NOS | Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-... | BeFree | 25080510 | Detail |
<0.001 | Dissection of aorta | NA | BeFree | Detail | |
<0.001 | Deep vein thrombosis of lower limb | NA | BeFree | Detail | |
<0.001 | Arteriovenous fistula thrombosis | Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis p... | BeFree | 24126814 | Detail |
<0.001 | Chronic liver disease | In conclusion, the use of ACE/Ang II/AT1 axis inhibitors associated with ACE2/An... | BeFree | 25453980 | Detail |
0.009 | Complications of Diabetes Mellitus | NA | GAD | Detail | |
<0.001 | Generalized glycogen storage disease of infants | NA | BeFree | Detail | |
<0.001 | Atrioventricular septal defect and common atrioventricular junction | NA | BeFree | Detail | |
<0.001 | Left ventricular dilatation | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | dysgerminoma of ovary | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Early gastric cancer | NA | BeFree | Detail | |
<0.001 | Ischemic cardiomyopathy | NA | BeFree | Detail | |
0.003 | Arrhythmogenic Right Ventricular Dysplasia | NA | BeFree,GAD | Detail | |
<0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | Overexpression of wt DCP1 led to a decrease in RSV-induced IL-8 production, but ... | BeFree | 25796077 | Detail |
0.002 | Cardiac Death | NA | GAD | Detail | |
0.011 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
0.080 | Endotoxemia | NA | RGD | Detail | |
0.002 | Atopy | NA | GAD | Detail | |
0.013 | thrombophilia | NA | BeFree,GAD | Detail | |
0.120 | Non-alcoholic Fatty Liver Disease | NA | CTD_human | Detail | |
0.001 | Steroid-sensitive nephrotic syndrome | NA | BeFree | Detail | |
<0.001 | Steroid-resistant nephrotic syndrome | NA | BeFree | Detail | |
0.006 | Chronic Kidney Insufficiency | NA | BeFree,GAD | Detail | |
<0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
<0.001 | Primary vesicoureteric reflux | NA | BeFree | Detail | |
<0.001 | Chronic small plaque psoriasis | NA | BeFree | Detail | |
0.005 | Osteoarthritis, Knee | NA | BeFree,GAD | Detail | |
0.013 | lupus erythematosus | NA | BeFree,GAD | Detail | |
<0.001 | Impaired exercise tolerance | NA | BeFree | Detail | |
<0.001 | Aortic valve calcification | NA | BeFree | Detail | |
<0.001 | Nephrotic range proteinuria | NA | BeFree | Detail | |
0.003 | Non-obstructive reflux-associated chronic pyelonephritis (disorder) | NA | BeFree,GAD | Detail | |
0.002 | Left ventricular mass | NA | GAD | Detail | |
<0.001 | Complex Regional Pain Syndromes | NA | BeFree | Detail | |
<0.001 | Respiratory distress | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
0.002 | Alzheimer Disease, Late Onset | NA | BeFree | Detail | |
0.014 | dementia | In 118 subjects from the memory clinic based Amsterdam Dementia Cohort (mean age... | BeFree,GAD | 25201786 | Detail |
0.011 | Overweight | NA | BeFree,GAD | Detail | |
<0.001 | Necrotizing Enterocolitis | NA | BeFree | Detail | |
<0.001 | acute pyelonephritis | NA | BeFree | Detail | |
0.013 | Sleep Apnea, Obstructive | Association of ACE I/D polymorphism with obstructive sleep apnea susceptibility:... | BeFree,GAD,LHGDN | 24271410 | Detail |
<0.001 | Granulomatosis | NA | BeFree | Detail | |
<0.001 | Bilateral cataracts (disorder) | NA | BeFree | Detail | |
<0.001 | Symptoms of stress | An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of ... | BeFree | 25921615 | Detail |
0.037 | Metabolic syndrome X | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
0.003 | Hepatitis C, Chronic | NA | BeFree,GAD | Detail | |
0.004 | Mood Disorders | NA | BeFree,GAD | Detail | |
<0.001 | Fluid overload | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
0.080 | endomyocardial fibrosis | NA | RGD | Detail | |
0.005 | Carotid Atherosclerosis | NA | BeFree,GAD | Detail | |
0.005 | Factor V Leiden mutation | NA | BeFree,GAD | Detail | |
0.002 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Neurogenic hypertension | Endoplasmic reticulum (ER) stress was previously reported to contribute to neuro... | BeFree | 25519733 | Detail |
<0.001 | genetic hypertension | NA | BeFree | Detail | |
0.008 | hyperhomocysteinemia | NA | BeFree,GAD,LHGDN | Detail | |
0.017 | systemic scleroderma | We examined the relationship between five gene polymorphisms [cytotoxic T lympho... | BeFree | 22173230 | Detail |
0.002 | prostate carcinoma | NA | BeFree | Detail | |
<0.001 | Activated Protein C Resistance | NA | BeFree | Detail | |
0.002 | hepatopulmonary syndrome | NA | GAD | Detail | |
0.080 | Ventricular Remodeling | NA | RGD | Detail | |
0.002 | Encounter due to convalescence | NA | GAD | Detail | |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
0.004 | breast carcinoma | NA | BeFree | Detail | |
0.002 | Carcinoma of lung | Angiotensin-converting enzyme insertion/deletion gene polymorphism and lung canc... | BeFree | 25354524 | Detail |
0.002 | Carcinoma of lung | Interaction of tobacco smoking and chewing with Angiotensin converting enzyme (i... | BeFree | 25605160 | Detail |
0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
<0.001 | nephronophthisis | NA | BeFree | Detail | |
0.002 | Pregnancy loss | NA | GAD | Detail | |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
0.003 | stomach carcinoma | Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer... | BeFree | 25154002 | Detail |
<0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
0.007 | Microalbuminuria | NA | BeFree | Detail | |
0.002 | Infarction, Middle Cerebral Artery | NA | GAD | Detail | |
<0.001 | Diabetic peripheral neuropathy | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | Cardiac defects | NA | BeFree | Detail | |
0.001 | cardiac event | NA | BeFree | Detail | |
0.002 | Cardiovascular Pathology | NA | BeFree | Detail | |
<0.001 | lymphangioleiomyomatosis | NA | BeFree | Detail | |
0.006 | brain infarction | NA | BeFree,GAD | Detail | |
0.002 | Intracranial Arterial Diseases | NA | GAD | Detail | |
<0.001 | Lewy Body Disease | We have measured endothelin-1 (ET-1) level and angiotensin-converting enzyme (AC... | BeFree | 24521289 | Detail |
<0.001 | Schizophrenia and related disorders | NA | BeFree | Detail | |
<0.001 | hypertensive nephropathy | NA | BeFree | Detail | |
<0.001 | Dry cough | NA | BeFree | Detail | |
0.002 | Sleep Disorders | NA | GAD | Detail | |
0.095 | Pregnancy associated hypertension | NA | GAD,LHGDN,RGD | Detail | |
0.002 | Blood Coagulation Disorders, Inherited | NA | GAD | Detail | |
<0.001 | Completed Suicide | NA | BeFree | Detail | |
0.003 | Arteriopathic disease | NA | BeFree,GAD | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
0.080 | Diabetic Cardiomyopathies | NA | RGD | Detail | |
<0.001 | Cognitive deterioration | NA | BeFree | Detail | |
0.005 | Endothelial dysfunction | NA | BeFree | Detail | |
<0.001 | Post MI | NA | BeFree | Detail | |
<0.001 | Pneumonitis | Genetic Association Between CD143 rs4340 Polymorphism and Pneumonia risk: A Meta... | BeFree | 26222869 | Detail |
0.462 | myocardial infarction | NA | CLINVAR | Detail | |
0.135 | Coughing | rs4340 polymorphism at intron 16 of the angiotensin-converting enzyme (CD143) ge... | BeFree | 26222869 | Detail |
0.440 | Hypertensive disease | A suggestive association with SBP (P=0.042), DBP (P=0.01) and hypertension (P=1.... | BeFree | 22456346 | Detail |
0.120 | IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO | NA | CLINVAR | Detail | |
0.246 | Coronary heart disease | Angiotensin-converting enzyme insertion/deletion (rs4340) and angiotensin II typ... | BeFree | 21722816 | Detail |
0.010 | pneumonia | Genetic Association Between CD143 rs4340 Polymorphism and Pneumonia risk: A Meta... | BeFree | 26222869 | Detail |
0.240 | MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 (finding) | NA | CLINVAR | Detail | |
<0.001 | Persistent dry cough | NA | BeFree | Detail | |
<0.001 | Nosocomial pneumonia | A significantly increased risk was also indicated under the recessive model in A... | BeFree | 26222869 | Detail |
0.001 | Community acquired pneumonia | A significantly increased risk was also indicated under the recessive model in A... | BeFree | 26222869 | Detail |
0.002 | Sarcopenia | NA | GAD | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
0.022 | Cardiomyopathies | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Insulin Sensitivity | NA | GAD | Detail | |
<0.001 | Vascular inflammations | NA | BeFree | Detail | |
0.033 | essential hypertension | The insertion/deletion (I/D) variant (rs4646994) of the angiotensin I-converting... | BeFree | 21993364 | Detail |
0.265 | coronary artery disease | [ACE (I/D) polymorphism and response to treatment in coronary artery disease: a ... | GAD | 19497121 | Detail |
0.016 | Ischemic stroke | Association between angiotensin converting enzyme gene insertion/deletion polymo... | BeFree,GAD | 24620983 | Detail |
0.016 | Ischemic stroke | Association between the ACE I/D polymorphism and risk of ischemic stroke: an upd... | BeFree,GAD | 25082780 | Detail |
0.004 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
0.010 | Leukoaraiosis | NA | GAD,LHGDN | Detail | |
0.002 | Nephroangiosclerosis | NA | GAD | Detail | |
0.143 | coronary restenosis | NA | BeFree,CTD_human,GAD | Detail | |
0.006 | Cardiomyopathy, Hypertrophic, Familial | NA | BeFree,GAD | Detail | |
0.005 | Spondylarthropathies | NA | BeFree,GAD,LHGDN | Detail | |
0.080 | Arthritis, Experimental | NA | RGD | Detail | |
0.002 | Macroangiopathy | NA | BeFree | Detail | |
0.006 | Heart Failure, Systolic | NA | BeFree,GAD | Detail | |
<0.001 | Chronic systolic heart failure | NA | BeFree | Detail | |
0.006 | Heart Failure, Diastolic | NA | BeFree,GAD | Detail | |
<0.001 | respiratory failure | NA | BeFree | Detail | |
0.125 | severe acute respiratory syndrome | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Drusen | NA | BeFree | Detail | |
0.003 | major depressive disorder | NA | BeFree | Detail | |
<0.001 | Mild cognitive disorder | NA | BeFree | Detail | |
0.005 | Blood pressure finding | NA | GAD | Detail | |
0.028 | Systemic arterial pressure | NA | GAD | Detail | |
<0.001 | First myocardial infarction | Three hundred and fifty six patients with first myocardial infarction (MI) were ... | BeFree | 23990179 | Detail |
<0.001 | Left ventricular systolic dysfunction | We enrolled 109 consecutive patients with left ventricular systolic dysfunction ... | BeFree | 25036270 | Detail |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Cardiovascular morbidity | Polymorphism of angiotensin converting enzyme in hemodialysis patients--associat... | BeFree | 25546976 | Detail |
<0.001 | Peripheral arterial occlusive disease | NA | BeFree | Detail | |
<0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | ATRIOVENTRICULAR CANAL DEFECT | NA | BeFree | Detail | |
<0.001 | atrioventricular septal defect | NA | BeFree | Detail | |
<0.001 | Cognitive changes | Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change ... | BeFree | 24577465 | Detail |
<0.001 | Cardiac fibrosis | NA | BeFree | Detail | |
0.003 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
0.006 | Mammary Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
0.011 | colorectal cancer | Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal... | BeFree,GAD | 25889770 | Detail |
0.002 | Erythrocytosis | NA | BeFree | Detail | |
0.002 | Creatinine finding | NA | GAD | Detail | |
0.003 | Chronic Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Overweight and obesity | The associations of 23 SNPs located within 17 candidate genes (MTHFR, PPARγ, LPL... | BeFree | 24959828 | Detail |
0.126 | Renal Insufficiency | NA | BeFree,CTD_human,GAD | Detail | |
0.001 | Alport syndrome | Although angiotensin-converting enzyme inhibition is effective in Alport syndrom... | BeFree | 24988067 | Detail |
<0.001 | Chronic uremia | NA | BeFree | Detail | |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
0.003 | Nephrotic Syndrome, Minimal Change | NA | BeFree | Detail | |
<0.001 | Hyperlipoproteinemia Type IIb | NA | BeFree | Detail | |
0.001 | Peripheral Arterial Diseases | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Primary Focal Segmental Glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | Severe Sepsis | NA | BeFree | Detail | |
<0.001 | Coronary heart disease, susceptibility to, 5 | NA | BeFree | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 2 | NA | BeFree,GAD | Detail | |
0.002 | ASPIRIN RESISTANCE | NA | GAD | Detail | |
<0.001 | Aural atresia, congenital | NA | BeFree | Detail | |
<0.001 | BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE | NA | BeFree | Detail | |
0.002 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | NA | BeFree | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 1 | NA | BeFree,GAD | Detail | |
0.002 | Hyperglycemia, Postprandial | NA | GAD | Detail | |
<0.001 | Nephronophthisis, familial juvenile | NA | BeFree | Detail | |
<0.001 | OVERLAP CONNECTIVE TISSUE DISEASE | NA | BeFree | Detail | |
<0.001 | ABLEPHARON-MACROSTOMIA SYNDROME | NA | BeFree | Detail | |
<0.001 | THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | NA | BeFree | Detail | |
0.013 | Venous thromboembolism | NA | GAD,LHGDN | Detail | |
0.001 | PANIC DISORDER 1 | The relationship between ACE polymorphism and panic disorder. | BeFree | 25189904 | Detail |
0.265 | coronary artery disease | The evaluation of angiotensin-converting enzyme (ACE) gene I/D and IL-4 gene int... | BeFree,CTD_human,GAD,LHGDN | 25189918 | Detail |
<0.001 | Transformed migraine | NA | BeFree | Detail | |
0.024 | Proteinuria Adverse Event | NA | GAD | Detail | |
0.002 | Memory Impairment Adverse Event | NA | GAD | Detail | |
<0.001 | CAKUT | NA | BeFree | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 4 | NA | BeFree,GAD | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 5 | NA | BeFree,GAD | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 6 | NA | BeFree,GAD | Detail | |
0.002 | Cicatrix | NA | GAD | Detail | |
<0.001 | Left Main Coronary Artery Stenosis | NA | BeFree | Detail | |
0.125 | liver carcinoma | In vivo, ACE-CD-EIIAFP-mediated suicide gene therapy efficiently suppressed HCC ... | BeFree,CTD_human,LHGDN | 25354682 | Detail |
0.011 | Chronic kidney disease stage 5 | Impact of interaction of cigarette smoking with angiotensin-converting enzyme po... | BeFree | 23477970 | Detail |
0.011 | Chronic kidney disease stage 5 | Although angiotensin-converting enzyme inhibition is effective in Alport syndrom... | BeFree | 24988067 | Detail |
<0.001 | Acute Anterior Wall Myocardial Infarction | NA | BeFree | Detail | |
<0.001 | Beryllium Disease | NA | BeFree | Detail | |
<0.001 | Chronic thromboembolic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Thrombophilia, hereditary | NA | BeFree | Detail | |
0.004 | Allergic rhinitis (disorder) | Angiotensin-converting enzyme insertion/deletion polymorphism associated with al... | BeFree,GAD | 24150611 | Detail |
0.004 | Allergic rhinitis (disorder) | Angiotensin-converting enzyme gene insertion/deletion polymorphisms and the susc... | BeFree,GAD | 24637107 | Detail |
0.080 | Acute kidney injury | NA | RGD | Detail | |
0.002 | Cerebral white matter lesion | NA | GAD | Detail | |
0.120 | MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1(finding) | NA | CTD_human | Detail | |
0.005 | SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding) | NA | GAD | Detail | |
0.003 | Major affective disorder 7 | NA | BeFree,GAD | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 8 | NA | BeFree,GAD | Detail | |
0.003 | MAJOR AFFECTIVE DISORDER 9 | NA | BeFree,GAD | Detail | |
<0.001 | Cerebral Small Vessel Diseases | ACE levels were not significantly related to measures of CSVD. | BeFree | 25201786 | Detail |
<0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
0.007 | Weight Loss Adverse Event | NA | GAD | Detail | |
0.012 | Weight Gain Adverse Event | NA | GAD | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
<0.001 | Low density lipoprotein receptor mutation | NA | BeFree | Detail | |
0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
0.002 | Recurrent pregnancy loss | NA | GAD | Detail | |
<0.001 | Amyloid angiopathy | NA | BeFree | Detail | |
0.127 | Cerebral Hemorrhage | NA | CTD_human,GAD,LHGDN | Detail | |
0.002 | thrombophilia due to thrombin defect | NA | GAD | Detail | |
<0.001 | Primary immunoglobulin A nephropathy (disorder) | NA | BeFree | Detail | |
0.002 | Hypotension Adverse Event | NA | GAD | Detail | |
0.002 | Aortic Stiffness | NA | GAD | Detail | |
0.001 | Stroke, Lacunar | NA | BeFree | Detail | |
<0.001 | Nonalcoholic Steatohepatitis | NA | BeFree | Detail | |
<0.001 | Three Vessel Coronary Disease | NA | BeFree | Detail | |
0.006 | Ischemic Cerebrovascular Accident | Association between angiotensin converting enzyme gene insertion/deletion polymo... | BeFree | 24620983 | Detail |
0.006 | Ischemic Cerebrovascular Accident | Association between the ACE I/D polymorphism and risk of ischemic stroke: an upd... | BeFree | 25082780 | Detail |
<0.001 | Homocysteinemia | NA | BeFree | Detail | |
0.003 | Juvenile arthritis | NA | BeFree,GAD | Detail | |
0.003 | Reflux nephropathy (disorder) | NA | BeFree,GAD | Detail | |
0.002 | granulomatosis with polyangiitis | NA | GAD | Detail | |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
<0.001 | Allergic disposition | NA | BeFree | Detail | |
<0.001 | aortic valve disease 2 | NA | BeFree | Detail | |
<0.001 | renal artery disease | NA | BeFree | Detail | |
<0.001 | Dementia due to Alzheimer's disease (disorder) | Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change ... | BeFree | 24577465 | Detail |
0.002 | Infection | NA | GAD | Detail | |
<0.001 | Insulin resistance syndrome | NA | BeFree | Detail | |
<0.001 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
<0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
0.003 | Congenital Abnormality | NA | BeFree,GAD | Detail | |
0.005 | Spontaneous abortion | NA | GAD,LHGDN | Detail | |
0.007 | Abortion, Habitual | NA | GAD | Detail | |
0.002 | Acidosis | NA | GAD | Detail | |
<0.001 | acute pancreatitis | The angiotensin-converting enzyme I (rather than D) allele was significantly ass... | BeFree | 24743610 | Detail |
0.122 | adenocarcinoma | NA | CTD_human,GAD | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
<0.001 | adrenal gland hyperfunction | NA | BeFree | Detail | |
<0.001 | agoraphobia | NA | BeFree | Detail | |
<0.001 | Airway Obstruction | NA | BeFree | Detail | |
0.144 | Albuminuria | NA | CTD_human,GAD,LHGDN | Detail | |
0.002 | Alcohol Amnestic Disorder | NA | GAD | Detail | |
0.008 | Alcoholic Intoxication, Chronic | NA | BeFree,GAD | Detail | |
<0.001 | alexithymia | NA | BeFree | Detail | |
0.024 | Altitude Sickness | NA | GAD | Detail | |
0.308 | Alzheimer's disease | To follow-up loci discovered by the International Genomics of Alzheimer's Diseas... | BeFree,CTD_human,GAD,LHGDN,RGD | 24495969 | Detail |
0.308 | Alzheimer's disease | Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer... | BeFree,CTD_human,GAD,LHGDN,RGD | 24851853 | Detail |
0.308 | Alzheimer's disease | This could suggest that ACE inhibitors, which may lower CSF ACE levels, are not ... | BeFree,CTD_human,GAD,LHGDN,RGD | 25201786 | Detail |
0.308 | Alzheimer's disease | Significant SNPs in ACE and MMP3 also showed association with AD risk. | BeFree,CTD_human,GAD,LHGDN,RGD | 25340798 | Detail |
0.308 | Alzheimer's disease | Angiotensin-converting enzyme insertion/deletion polymorphism is not a major det... | BeFree,CTD_human,GAD,LHGDN,RGD | 25360660 | Detail |
0.308 | Alzheimer's disease | In vitro and in vivo experiments revealed that four drugs, all of which are angi... | BeFree,CTD_human,GAD,LHGDN,RGD | 25446738 | Detail |
0.308 | Alzheimer's disease | We aimed to assess the specificity of pAβ for AD and have investigated associati... | BeFree,CTD_human,GAD,LHGDN,RGD | 25556395 | Detail |
0.308 | Alzheimer's disease | Association of PS1 1/2, ACE I/D, and LRP C/T polymorphisms with Alzheimer's dise... | BeFree,CTD_human,GAD,LHGDN,RGD | 25730041 | Detail |
0.002 | Amnesia | NA | GAD | Detail | |
0.003 | anemia | NA | BeFree,GAD | Detail | |
0.005 | Anemia, Sickle Cell | NA | BeFree,GAD | Detail | |
0.001 | Aneurysm | NA | BeFree | Detail | |
0.005 | Angina Pectoris | NA | GAD | Detail | |
<0.001 | Angina Pectoris, Variant | NA | BeFree | Detail | |
0.003 | Angina, Unstable | NA | BeFree,GAD | Detail | |
0.002 | Fabry disease | NA | GAD | Detail | |
0.005 | angioedema | NA | GAD | Detail | |
0.002 | Anoxemia | NA | GAD | Detail | |
0.009 | Anoxia | NA | GAD | Detail | |
<0.001 | antisocial personality disorder | NA | BeFree | Detail | |
<0.001 | anuria | NA | BeFree | Detail | |
0.001 | Anxiety Disorders | NA | BeFree | Detail | |
0.002 | aortic aneurysm | Associations between the insertion/deletion polymorphism of the angiotensin-conv... | BeFree | 23587545 | Detail |
0.002 | aortic aneurysm | Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-... | BeFree | 25080510 | Detail |
0.002 | Aortic Diseases | NA | GAD | Detail | |
0.005 | aortic valve insufficiency | NA | BeFree,GAD | Detail | |
0.011 | aortic valve stenosis | NA | BeFree,GAD,LHGDN | Detail | |
0.125 | Cardiac arrhythmia | NA | CTD_human,GAD,LHGDN | Detail | |
0.007 | Arterial Occlusive Diseases | NA | GAD | Detail | |
0.020 | arteriosclerosis | NA | BeFree,GAD | Detail | |
<0.001 | Arteriovenous fistula | NA | BeFree | Detail | |
0.005 | arthritis | NA | GAD | Detail | |
0.008 | Arthritis, Psoriatic | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | rheumatoid arthritis | The angiotensin-converting enzyme insertion/deletion polymorphism and susceptibi... | BeFree,GAD | 23413281 | Detail |
0.002 | Asphyxia | NA | GAD | Detail | |
<0.001 | aspirin intolerance | NA | BeFree | Detail | |
0.041 | asthma | NA | BeFree,GAD,LHGDN | Detail | |
0.056 | atherosclerosis | NA | BeFree,GAD | Detail | |
0.152 | atrial fibrillation | NA | CTD_human,GAD,LHGDN | Detail | |
0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
0.002 | azoospermia | NA | GAD | Detail | |
0.003 | Back Pain | NA | BeFree,LHGDN | Detail | |
<0.001 | Nonproliferative diabetic retinopathy | NA | BeFree | Detail | |
<0.001 | Bacteremia | Gram-positive bacteremia was more common in ACE for ID versus DD genotype. | BeFree | 24819208 | Detail |
0.002 | Mental disorders | The angiotensin converting enzyme (ACE) gene, which has been found to have an in... | BeFree | 25189904 | Detail |
0.014 | Behcet Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.120 | berylliosis | NA | CTD_human | Detail | |
0.002 | beta thalassemia | NA | GAD | Detail | |
0.091 | bipolar disorder | NA | BeFree,GAD,RGD | Detail | |
0.002 | Malignant neoplasm of urinary bladder | NA | GAD | Detail | |
0.002 | borderline personality disorder | NA | BeFree | Detail | |
0.024 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
0.080 | bronchiolitis obliterans | NA | RGD | Detail | |
0.009 | bronchopulmonary dysplasia | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Cachexia | NA | BeFree,GAD | Detail | |
0.012 | calcinosis | NA | GAD | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
0.003 | Non-small cell lung carcinoma | NA | BeFree,GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systemati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In 118 subjects from the memory clinic based Amsterdam Dementia Cohort (mean age 66 ± 8 years), ACE ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Previous studies have revealed the association of the ACE gene insertion/deletion polymorphism with ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Non-dipping and arterial hypertension depend on clinical factors rather than on genetic variability ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The distribution of ACE (I/D) II 28.8%, ID 35.6% and DD 35.6% while in DN II 24.5%, ID 41% and DD 34... | DisGeNET | Detail |
ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic infor... | DisGeNET | Detail |
Genetic variants in angiotensin-converting enzyme (ACE), tumor necrosis factor-alpha (TNF-α) and ery... | DisGeNET | Detail |
Influence of genetic variability at the ACE locus in intron 16 on Diabetic Nephropathy in T1DM patie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The mechanisms may include the following pathways: [TGFB1 or TNFA]-[IL1B]-[pre-eclampsia]; [TNFA or ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin converting enzyme and methylenetetrahydrofolate reductase gene variations in fibromyalgi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ACE insertion/deletion polymorphism is associated with periodontal disease in Korean population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Based on some research evidence, treatment with angiotensin-converting enzyme inhibitors, b-blockers... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The HF pharmacogenetic literature is still in its very early stages, but there are promising candida... | DisGeNET | Detail |
The HF pharmacogenetic literature is still in its very early stages, but there are promising candida... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To design a tumor-specific retroviral replicating vector (RRV), we replaced the U3 region of the RRV... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The FXII-HAE is associated with modifiers, for example kinin catabolism enzymes, ACE and CPN, differ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIV status was associated with significantly increased expression of CD64, CD143 and CD163 on CD16+ ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ACE genotype and salt status do not impact on insulin sensitivity through changes in limb blood flow... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The angiotensin-converting enzyme gene polymorphism is associated with the development of cerebrovas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In comparison tests with Seeplex RV15 ACE Detection RT-PCR, the sensitivity of the Verigene RV+ kit ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Impact of interaction of cigarette smoking with angiotensin-converting enzyme polymorphisms on end-s... | DisGeNET | Detail |
Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We conclude that the ACE gene I/D polymorphism is not related with the size or number of ULM fibroid... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To investigate the possible relationship between genetic risk factors and depression in AD, we asses... | DisGeNET | Detail |
To investigate the possible relationship between genetic risk factors and depression in AD, we asses... | DisGeNET | Detail |
To investigate the possible relationship between genetic risk factors and depression in AD, we asses... | DisGeNET | Detail |
To investigate the possible relationship between genetic risk factors and depression in AD, we asses... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructiv... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: a systematic revie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between the ACE gene I/D polymorphism and osteoporosis in a Turkish population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic efficacy of salvianolat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic efficacy of salvianolat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The relationship between ACE polymorphism and panic disorder. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting enzyme ACE (I/D) (rs46... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ACE insertion/deletion polymorphism is associated with periodontal disease in Korean population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to rheumatoid a... | DisGeNET | Detail |
Evaluation of the association between CD143 gene polymorphism and psoriasis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between the ACE insertion/deletion polymorphism and pterygium in Sardinian patients: a p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results suggest that DCP1 phosphorylation modulates the host chemokine response to RSV infecti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptib... | DisGeNET | Detail |
In this study, we developed a new method for genotyping the I/D polymorphism in ACE and established ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of angiotensin-converting enzyme gene polymorphism with schizophrenia and depressive sym... | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to systemic scleros... | DisGeNET | Detail |
We investigated misspecification, and found that fitting the standard ACE simplex to covariance matr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased susceptibility of sepsis associated with CD143 deletion/insertion polymorphism in Caucasia... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The genetic contribution of CD143 ID polymorphism to the progression of psoriasis, the commonest ski... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Common antihypertensive medication classes of angiotensin-converting enzyme inhibitors (ACE-Is) and ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In pharmacogenetic analysis, the increased risk of stroke in subjects carrying G-6 was eliminated by... | DisGeNET | Detail |
The angiotensin-converting enzyme gene polymorphism is associated with the development of cerebrovas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this paper we show that upon an appropriate design of the biorecognition platform, efficient sand... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Lack of influence of the ACE1 gene I/D polymorphism on the formation and growth of benign uterine le... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme gene insertion/deletion polymorphism studies in Asian Indian pregnant ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ACE I/D, AGT M235T, and ADD Gly460Trp polymorphisms are thought to be associated with primary hypert... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the mannose-binding lectin 2 (MBL-2), interleukin (IL)-4, T... | DisGeNET | Detail |
Association of angiotensin-converting enzyme gene polymorphism with schizophrenia and depressive sym... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In patients with contraindications or not responding to conventional prophylactic drugs and in patie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting enzyme ACE (I/D) (rs46... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We suggest that RAS gene polymorphisms (ACE-I/D, AGT M235T) are significantly associated with suscep... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A meta-analysis was conducted on the associations between the ACE I/D polymorphism and all AAs and a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
BH-DIH prevalence was significantly higher in subjects showing ACE ID genotype (34.5%) than II (0%, ... | DisGeNET | Detail |
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, both AT1 blocker administration and ACE inhibitors lead to a reduction in inflammation ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion gene polymorphism and lung cancer risk: A meta-anal... | DisGeNET | Detail |
Interaction of tobacco smoking and chewing with Angiotensin converting enzyme (insertion/deletion) g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The sample consisted of 205 subjects assessed for five types of episodic memory, using Wechsler Memo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased susceptibility of sepsis associated with CD143 deletion/insertion polymorphism in Caucasia... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (pro)renin receptor (r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Positive Association of D Allele of ACE Gene With High Altitude Pulmonary Edema in Indian Population... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations between the insertion/deletion polymorphism of the angiotensin-converting enzyme and su... | DisGeNET | Detail |
Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arterio... | DisGeNET | Detail |
In conclusion, the use of ACE/Ang II/AT1 axis inhibitors associated with ACE2/Ang(1-7)/Mas axis acti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of wt DCP1 led to a decrease in RSV-induced IL-8 production, but this effect was abro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In 118 subjects from the memory clinic based Amsterdam Dementia Cohort (mean age 66 ± 8 years), ACE ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of ACE I/D polymorphism with obstructive sleep apnea susceptibility: evidence based on 2... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Endoplasmic reticulum (ER) stress was previously reported to contribute to neurogenic hypertension w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We examined the relationship between five gene polymorphisms [cytotoxic T lymphocyte associated anti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion gene polymorphism and lung cancer risk: A meta-anal... | DisGeNET | Detail |
Interaction of tobacco smoking and chewing with Angiotensin converting enzyme (insertion/deletion) g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: a systematic revie... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We have measured endothelin-1 (ET-1) level and angiotensin-converting enzyme (ACE) activity in the o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic Association Between CD143 rs4340 Polymorphism and Pneumonia risk: A Meta Analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
rs4340 polymorphism at intron 16 of the angiotensin-converting enzyme (CD143) gene was reported to r... | DisGeNET | Detail |
A suggestive association with SBP (P=0.042), DBP (P=0.01) and hypertension (P=1.4 × 10(-5)) was also... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion (rs4340) and angiotensin II type 1 receptor A1166C ... | DisGeNET | Detail |
Genetic Association Between CD143 rs4340 Polymorphism and Pneumonia risk: A Meta Analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A significantly increased risk was also indicated under the recessive model in Asian populations (FE... | DisGeNET | Detail |
A significantly increased risk was also indicated under the recessive model in Asian populations (FE... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The insertion/deletion (I/D) variant (rs4646994) of the angiotensin I-converting enzyme (ACE) gene i... | DisGeNET | Detail |
[ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive databa... | DisGeNET | Detail |
Association between angiotensin converting enzyme gene insertion/deletion polymorphism and ischemic ... | DisGeNET | Detail |
Association between the ACE I/D polymorphism and risk of ischemic stroke: an updated meta-analysis o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Three hundred and fifty six patients with first myocardial infarction (MI) were followed up during a... | DisGeNET | Detail |
We enrolled 109 consecutive patients with left ventricular systolic dysfunction [left ventricular ej... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymorphism of angiotensin converting enzyme in hemodialysis patients--association with cardiovascu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systemati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The associations of 23 SNPs located within 17 candidate genes (MTHFR, PPARγ, LPL, INSIG, TCF7L2, FTO... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The relationship between ACE polymorphism and panic disorder. | DisGeNET | Detail |
The evaluation of angiotensin-converting enzyme (ACE) gene I/D and IL-4 gene intron 3 VNTR polymorph... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In vivo, ACE-CD-EIIAFP-mediated suicide gene therapy efficiently suppressed HCC tumor growth and no ... | DisGeNET | Detail |
Impact of interaction of cigarette smoking with angiotensin-converting enzyme polymorphisms on end-s... | DisGeNET | Detail |
Although angiotensin-converting enzyme inhibition is effective in Alport syndrome patients for slowi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion polymorphism associated with allergic rhinitis susc... | DisGeNET | Detail |
Angiotensin-converting enzyme gene insertion/deletion polymorphisms and the susceptibility to allerg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ACE levels were not significantly related to measures of CSVD. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between angiotensin converting enzyme gene insertion/deletion polymorphism and ischemic ... | DisGeNET | Detail |
Association between the ACE I/D polymorphism and risk of ischemic stroke: an updated meta-analysis o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dem... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The angiotensin-converting enzyme I (rather than D) allele was significantly associated with alcohol... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attemp... | DisGeNET | Detail |
Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer's disease: a meta-a... | DisGeNET | Detail |
This could suggest that ACE inhibitors, which may lower CSF ACE levels, are not preferred as antihyp... | DisGeNET | Detail |
Significant SNPs in ACE and MMP3 also showed association with AD risk. | DisGeNET | Detail |
Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in t... | DisGeNET | Detail |
In vitro and in vivo experiments revealed that four drugs, all of which are angiotensin-converting e... | DisGeNET | Detail |
We aimed to assess the specificity of pAβ for AD and have investigated associations of pAβ with pare... | DisGeNET | Detail |
Association of PS1 1/2, ACE I/D, and LRP C/T polymorphisms with Alzheimer's disease in the Chinese p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations between the insertion/deletion polymorphism of the angiotensin-converting enzyme and su... | DisGeNET | Detail |
Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to rheumatoid a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gram-positive bacteremia was more common in ACE for ID versus DD genotype. | DisGeNET | Detail |
The angiotensin converting enzyme (ACE) gene, which has been found to have an insertion and deletion... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386602118 dbSNP
- Genome
- hg19
- Position
- chr17:61,554,422-61,575,741
- Variant Type
- snv
Genome browser